Detalles de la búsqueda
1.
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells.
J Clin Invest;
2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38833312
2.
OBITUARY- Riccardo Saccardi (20th April 1956-19th February 2024).
Bone Marrow Transplant;
2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38693317
3.
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity.
Ann Hematol;
2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38695872
4.
Correction to: Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy.
Neurol Sci;
2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38573433
5.
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation.
Blood Cancer J;
14(1): 45, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38485723
6.
CMV-RNAemia as new marker of active viral replication in transplant recipients.
J Clin Microbiol;
62(5): e0163023, 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38534109
7.
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study.
Leukemia;
38(5): 1107-1114, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38459167
8.
Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy.
Neurol Sci;
2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38512531
9.
Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor.
Bone Marrow Transplant;
59(5): 597-603, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38331980
10.
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.
Lancet Haematol;
11(2): e147-e159, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38184001
11.
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study.
BMC Health Serv Res;
24(1): 121, 2024 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38254079
12.
Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients.
Mediterr J Hematol Infect Dis;
16(1): e2024004, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38223480
13.
Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma.
Leuk Lymphoma;
65(3): 399-402, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38069804
14.
Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: Not all is lost!
Br J Haematol;
204(3): 1109-1113, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38111196
15.
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer;
129(23): 3735-3745, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37658621
16.
GVHD: better safe than sorry.
Blood;
142(8): 680-682, 2023 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37616024
17.
Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T-cell pathway in patients with diffuse large B-cell lymphoma.
Hematol Oncol;
41(5): 947-950, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37442805
18.
Impact of a newly established expert clinical pharmacological advice programme based on therapeutic drug monitoring results in tailoring antimicrobial therapy hospital-wide in a tertiary university hospital: Findings after the first year of implementation.
Int J Antimicrob Agents;
62(2): 106884, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37302773
19.
CAR t-cell therapy in BOlogNa-NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON-NEUTRAL): proposed protocol and results from an Italian study.
J Neurol;
270(5): 2659-2673, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36869888
20.
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study.
Pharmaceutics;
15(3)2023 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36986882